Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN

Stegelmann, Frank; Wille, Kai; Marchi, Hannah; Fuchs, Christiane; Schauer, Stefanie; Sadjadian, Parvis; Becker, Tatjana; Kolatzki, Vera; Döhner, Hartmut; Stadler, Rudolf; Döhner, Konstanze; Griesshammer, Martin

Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN

Stegelmann F, Wille K, Marchi H, Fuchs C, Schauer S, Sadjadian P, Becker T, Kolatzki V, Döhner H, Stadler R, Döhner K, et al. (2021)
Leukemia 35: 3635.

Zeitschriftenaufsatz | Veröffentlicht | Englisch

Download

Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!

DOI

https://doi.org/10.1038/s41375-021-01366-3

Autor*in

Stegelmann, Frank; Wille, Kai; Marchi, Hannah^UniBi ; Fuchs, Christiane^UniBi ; Schauer, Stefanie; Sadjadian, Parvis; Becker, Tatjana; Kolatzki, Vera; Döhner, Hartmut; Stadler, Rudolf; Döhner, Konstanze; Griesshammer, Martin

Einrichtung

Fakultät für Wirtschaftswissenschaften > Lehrstuhl für Data Science

Erscheinungsjahr

2021

Zeitschriftentitel

Leukemia

Band

35

Seite(n)

3635

Urheberrecht / Lizenzen

Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0)

ISSN

0887-6924

eISSN

1476-5551

Page URI

https://pub.uni-bielefeld.de/record/2959082

Zitieren

Stegelmann F, Wille K, Marchi H, et al. Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia. 2021;35:3635.

Stegelmann, F., Wille, K., Marchi, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., et al. (2021). Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia, 35, 3635. https://doi.org/10.1038/s41375-021-01366-3

Stegelmann, Frank, Wille, Kai, Marchi, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, et al. 2021. “Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”. Leukemia 35: 3635.

Stegelmann, F., Wille, K., Marchi, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., Kolatzki, V., Döhner, H., Stadler, R., et al. (2021). Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia 35, 3635.

Stegelmann, F., et al., 2021. Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia, 35, p 3635.

F. Stegelmann, et al., “Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”, Leukemia, vol. 35, 2021, pp. 3635.

Stegelmann, F., Wille, K., Marchi, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., Kolatzki, V., Döhner, H., Stadler, R., Döhner, K., Griesshammer, M.: Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia. 35, 3635 (2021).

Stegelmann, Frank, Wille, Kai, Marchi, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, Kolatzki, Vera, Döhner, Hartmut, Stadler, Rudolf, Döhner, Konstanze, and Griesshammer, Martin. “Publisher Correction: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”. Leukemia 35 (2021): 3635.

Daten bereitgestellt von European Bioinformatics Institute (EBI)